|

Recombinant Human Granulocyte Colony-Stimulating Factor Clinical Trials

1 actively recruiting trial

Also known as: Recombinant Human Granulocyte Colony-Stimulating Factor Injection

Pipeline

Phase 2: 1

Top Sponsors

  • Children's Hospital of Soochow University1

Indications

  • Acute Myeloid Leukemia1
  • AML, Childhood1
  • Cancer1

Other1 trial

Clinical Study of Induction Therapy Options Based on Molecular Subtyping and MRD in Children and Adolescents With AML
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.